未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial 在CheckMate 9LA随机试验中，转移性非小细胞肺癌患者一线nivolumab联合ipilimumab进行2周期化疗与单独4周期化疗的五年结果 Reck, Martin; Ciuleanu, Tudor-Eliade; Schenker, Michael; Bordenave, Stephanie; Cobo, Manuel; Juan-Vidal, Oscar; Reinmuth, Niels; Richardet, Eduardo; Felip, Enriqueta; Menezes, Juliana; Cheng, Ying; Mizutani, Hideaki; Zurawski, Bogdan; Alexandru, Aurelia; Carbone, David P.; Lu, Shun; John, Thomas; Aoyama, Takekazu; Grootendorst, Diederik J.; Hu, Nan; Eccles, Laura J.; Paz-Ares, Luis G. 分享 收藏
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC Amivantamab联合Lazertinib治疗先前未经治疗的EGFR突变的晚期NSCLC Cho, Byoung C.; Lu, Shun; Felip, Enriqueta; Spira, Alexander I.; Girard, Nicolas; Lee, Jong-Seok; Lee, Se-Hoon; Ostapenko, Yurii; Danchaivijitr, Pongwut; Liu, Baogang; Alip, Adlinda; Korbenfeld, Ernesto; Mourao Dias, Josiane; Besse, Benjamin; Lee, Ki-Hyeong; Xiong, Hailin; How, Soon-Hin; Cheng, Ying; Chang, Gee-Chen; Yoshioka, Hiroshige; Yang, James C. -H.; Thomas, Michael; Nguyen, Danny; Ou, Sai-Hong I.; Mukhedkar, Sanjay; Prabhash, Kumar; D'Arcangelo, Manolo; Alatorre-Alexander, Jorge; Vazquez Limon, Juan C.; Alves, Sara; Stroyakovskiy, Daniil; Peregudova, Marina; Sendur, Mehmet A. N.; Yazici, Ozan; Califano, Raffaele; Gutierrez Calderon, Vanesa; de Marinis, Filippo; Passaro, Antonio; Kim, Sang-We; Gadgeel, Shirish M.; Xie, John; Sun, Tao; Martinez, Melissa; Ennis, Mariah; Fennema, Elizabeth; Daksh, Mahesh; Millington, Dawn; Leconte, Isabelle; Iwasawa, Ryota; Lorenzini, Patricia; Baig, Mahadi; Shah, Sujay; Bauml, Joshua M.; Shreeve, S. Martin; Sethi, Seema; Knoblauch, Roland E.; Hayashi, Hidetoshi 分享 收藏
MK-2870-004: A phase 3 study of MK-2870 (SKB264) versus chemotherapy for previously treated advanced or metastatic nonsquamous non-small-cell lung cancer (NSCLC) with EGFR mutations or other genomic alterations Cappuzzo, Federico; Garon, Edward B.; Ahn, Myung-Ju; Lu, Shun; Kato, Terufumi; Felip, Enriqueta; Cheema, Parneet; Girard, Nicolas; Shamoun, Mark; Wang, Guoqing; Zhao, Bin; Hui, Rina 分享 收藏
A phase 1/2a, multicenter, open-label, non-randomized first-in-human study to assess the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of DB-1310 (a HER3-targeting ADC) in patients with advanced/metastatic solid tumors Lisberg, Aaron; Lu, Shun; Starodub, Alexander; Amin, Harshad; Rotow, Julia; Wu, Lin; Spira, Alexander; Hamilton, Erika; Shen, Weidi; Liu, Liming; Zhu, Zhongyuan; Gu, Wei; Qiu, Yang; Shi, Rong; Liu, Shengxue 分享 收藏
分享 收藏
KRYSTAL-7: Efficacy and safety of adagrasib with pembrolizumab in patients with treatment-naive, advanced non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation Garassino, M. C.; Theelen, W. S. M. E.; Jotte, R.; Laskin, J.; De Marinis, F.; Aguado, C.; Badin, F. B.; Chmielewska, I.; Hochmair, M. J.; Lu, S.; Nadal, E.; Ostoros, G.; Felip, E.; Spira, A. I.; Lane, C. M.; He, J.; Chao, R.; Janne, P. A. 分享 收藏
Neoadjuvant nivolumab (N) plus chemotherapy (C) in the phase III CheckMate 816 study: 3-y results by tumor PD-L1 expression Pulla, M. Provencio; Forde, P. M.; Spicer, J. D.; Wang, C.; Lu, S.; Mitsudomi, T.; Awad, M. M.; Felip, E.; Broderick, S.; Swanson, S. J.; Brahmer, J. R.; Kerr, K. M.; Saylors, G.; Tanaka, F.; Chen, K. N.; Tran, M. P.; Cai, J. L.; Mahmood, J.; Meadows-Shropshire, S.; Girard, N. 分享 收藏
分享 收藏
Longitudinal ctDNA levels and clinical outcomes of first-line (1L) tislelizumab (TIS) plus chemotherapy (chemo) treatment for advanced non-small cell lung cancer (NSCLC) in the RATIONALE-304 and 307 studies Lu, Shun; Wang, Jie; Sun, Meili; Zhao, Jun; Hu, Chunhong; Wang, Mengzhao; Zhou, Jianying; Song, Yong; Zhou, Qinghua; Zhang, Jiayuan; Shi, Yang; Huang, Ruiqi; Wu, Xikun; He, Wanyu; Qu, Xiaofei; Zhang, Yun; Shen, Zhirong; Yu, Yan 分享 收藏
Neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in Chinese patients (pts) with resectable NSCLC in CheckMate 816 Wang, Changli; Chen, Ke-Neng; Chen, Qixun; Wu, Lin; Wang, Qun; Li, Xiaofei; Ying, Kejing; Wang, Wenxiang; Zhao, Jian; Liu, Lunxu; Fu, Junke; Zhang, Chunfang; Liu, Jichun; Hu, Yi; Awad, Mark M.; Ntambwe, Ives; Cai, Junliang; Bushong, Judith; Phuong Tran; Lu, Shun 分享 收藏
分享 收藏
Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non-small-cell lung cancer Forde, Patrick M.; Spicer, Jonathan; Lu, Shun; Provencio, Mariano; Mitsudomi, Tetsuya; Awad, Mark M.; Felip, Enriqueta; Broderick, Stephen R.; Brahmer, Julie R.; Swanson, Scott J.; Kerr, Keith; Wang, Changli; Ciuleanu, Tudor-Eliade; Saylors, Gene B.; Tanaka, Fumihiro; Ito, Hiroyuki; Chen, Ke Neng; Liberman, Moishe; Vokes, Everett E.; Taube, Janis M.; Dorange, Cecile; Cai, Junliang; Fiore, Joseph; Jarkowski, Anthony; Balli, David; Sausen, Mark; Pandya, Dimple; Calvet, Christophe Y.; Girard, Nicolas 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏